COMBINED THERAPY WITH CO-AMOXICLAV AND ERYTHROMYCIN AGAINST INTRACELLULAR LEGIONELLA-PNEUMOPHILA IN CELL - CULTURE AND IN AN EXPERIMENTAL RESPIRATORY-INFECTION IN NEUTROPENIC RATS
Gm. Smith et al., COMBINED THERAPY WITH CO-AMOXICLAV AND ERYTHROMYCIN AGAINST INTRACELLULAR LEGIONELLA-PNEUMOPHILA IN CELL - CULTURE AND IN AN EXPERIMENTAL RESPIRATORY-INFECTION IN NEUTROPENIC RATS, Journal of antimicrobial chemotherapy, 35(6), 1995, pp. 889-893
A combination of co-amoxiclav and erythromycin has been shown in these
studies to be more effective than either agent alone against intracel
lular Legionella pneumophila in MRC-5 cells and following oral adminis
tration in an experimental respiratory infection in neutropenic rats.